These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32994821)

  • 21. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coenzyme Q10 supplementation alleviates pain in pregabalin-treated fibromyalgia patients
    Sawaddiruk P; Apaijai N; Paiboonworachat S; Kaewchur T; Kasitanon N; Jaiwongkam T; Kerdphoo S; Chattipakorn N; Chattipakorn SC
    Free Radic Res; 2019 Aug; 53(8):901-909. PubMed ID: 31387429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
    Zeng H; Liu Z; Wang Z; Zhou Q; Qi Y; Chen Y; Chen L; Zhang P; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
    Int J Cancer; 2020 Jan; 146(2):542-552. PubMed ID: 31584197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
    Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
    J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coenzyme Q
    Yu JH; Lim SW; Luo K; Cui S; Quan Y; Shin YJ; Lee KE; Kim HL; Ko EJ; Chung BH; Kim JH; Chung SJ; Yang CW
    FASEB J; 2019 Nov; 33(11):12288-12298. PubMed ID: 31431058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancer.
    Kato K; Doki Y; Ura T; Hamamoto Y; Kojima T; Tsushima T; Hironaka S; Hara H; Kudo T; Iwasa S; Muro K; Yasui H; Minashi K; Yamaguchi K; Ohtsu A; Kitagawa Y
    Cancer Sci; 2020 May; 111(5):1676-1684. PubMed ID: 32160365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coenzyme Q10 Exerts Anti-Inflammatory Activity and Induces Treg in Graft Versus Host Disease.
    Lee SH; Park MJ; Lee SH; Cho ML
    J Med Food; 2016 Mar; 19(3):238-44. PubMed ID: 26872287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement.
    Di Lorenzo A; Iannuzzo G; Parlato A; Cuomo G; Testa C; Coppola M; D'Ambrosio G; Oliviero DA; Sarullo S; Vitale G; Nugara C; Sarullo FM; Giallauria F
    J Clin Med; 2020 Apr; 9(5):. PubMed ID: 32349341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Adjuvant Therapy with Molecular Hydrogen on Endogenous Coenzyme Q
    Sumbalová Z; Kucharská J; Rausová Z; Gvozdjáková A; Szántová M; Kura B; Mojto V; Slezák J
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic treatment with coenzyme Q10 in patients undergoing cardiac surgery: could an antioxidant reduce complications? A systematic review and meta-analysis.
    de Frutos F; Gea A; Hernandez-Estefania R; Rabago G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):254-9. PubMed ID: 25344142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor mutational load, CD8
    Hurkmans DP; Kuipers ME; Smit J; van Marion R; Mathijssen RHJ; Postmus PE; Hiemstra PS; Aerts JGJV; von der Thüsen JH; van der Burg SH
    Cancer Immunol Immunother; 2020 May; 69(5):771-777. PubMed ID: 32047958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coenzyme Q10 mitigates ionizing radiation-induced testicular damage in rats through inhibition of oxidative stress and mitochondria-mediated apoptotic cell death.
    Said RS; Mohamed HA; Kamal MM
    Toxicol Appl Pharmacol; 2019 Nov; 383():114780. PubMed ID: 31618661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TIM-3 as a marker of exhaustion in CD8
    Mohammadizad H; Shahbazi M; Hasanjani Roushan MR; Soltanzadeh-Yamchi M; Mohammadnia-Afrouzi M
    Microb Pathog; 2019 Mar; 128():323-328. PubMed ID: 30660734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer.
    Bagley SJ; Kothari S; Aggarwal C; Bauml JM; Alley EW; Evans TL; Kosteva JA; Ciunci CA; Gabriel PE; Thompson JC; Stonehouse-Lee S; Sherry VE; Gilbert E; Eaby-Sandy B; Mutale F; DiLullo G; Cohen RB; Vachani A; Langer CJ
    Lung Cancer; 2017 Apr; 106():1-7. PubMed ID: 28285682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation.
    Masotta NE; Martinefski MR; Lucangioli S; Rojas AM; Tripodi VP
    Int J Pharm; 2019 Feb; 556():9-20. PubMed ID: 30529659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low PD-1 Expression in Cytotoxic CD8
    Mazzaschi G; Madeddu D; Falco A; Bocchialini G; Goldoni M; Sogni F; Armani G; Lagrasta CA; Lorusso B; Mangiaracina C; Vilella R; Frati C; Alfieri R; Ampollini L; Veneziani M; Silini EM; Ardizzoni A; Urbanek K; Aversa F; Quaini F; Tiseo M
    Clin Cancer Res; 2018 Jan; 24(2):407-419. PubMed ID: 29074606
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of PD-1 blockade in cervical cancer is related to a CD8
    Heeren AM; Rotman J; Stam AGM; Pocorni N; Gassama AA; Samuels S; Bleeker MCG; Mom CH; Zijlmans HJMAA; Kenter GG; Jordanova ES; de Gruijl TD
    J Immunother Cancer; 2019 Feb; 7(1):43. PubMed ID: 30755279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Cellular Coenzyme Q
    Heaton RA; Heales S; Rahman K; Sexton DW; Hargreaves I
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32575494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients.
    Osa A; Uenami T; Koyama S; Fujimoto K; Okuzaki D; Takimoto T; Hirata H; Yano Y; Yokota S; Kinehara Y; Naito Y; Otsuka T; Kanazu M; Kuroyama M; Hamaguchi M; Koba T; Futami Y; Ishijima M; Suga Y; Akazawa Y; Machiyama H; Iwahori K; Takamatsu H; Nagatomo I; Takeda Y; Kida H; Akbay EA; Hammerman PS; Wong KK; Dranoff G; Mori M; Kijima T; Kumanogoh A
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutations.
    Sato M; Watanabe S; Tanaka H; Nozaki K; Arita M; Takahashi M; Shoji S; Ichikawa K; Kondo R; Aoki N; Hayashi M; Ohshima Y; Koya T; Ohashi R; Ajioka Y; Kikuchi T
    PLoS One; 2019; 14(4):e0215292. PubMed ID: 30978241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.